Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s

Navigating neuroimaging in Alzheimer disease care

PET imaging is playing an increasingly critical role in managing AD, but how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.
ADVANCED SEARCH
Log in

Oncology

The evolving treatment landscape of advanced prostate cancer

The advent of PSMA-targeted radioligand therapies and bispecific T-cell engagers has provided new hope for patients with metastatic castration-resistant prostate cancer. Explore the latest evidence.

Read more

Editor's Choice

Reassuring results for ART use in BRCA breast cancer survivors

The use of assisted reproductive technology to conceive after breast cancer in young BRCA1/2 carriers does not appear to worsen disease-free survival or pregnancy outcomes.

A-RT promising for high-risk patients with pancreatic cancer

Ablative radiation therapy can be an alternative option to surgery for the treatment of localized, resectable pancreatic ductal adenocarcinoma, particularly in cases of high surgical risk.

YKL-40 linked to GI cancer risk in type 2 diabetes

Raised YKL-40 levels are associated with an increased risk for obesity-related and gastrointestinal cancers, particularly liver cancer, in people with type 2 diabetes.

Gastric cancer guidelines: exploring international differences

What can we learn from the similarities and differences between gastric cancer guidelines of different countries, and how might this understanding be used to improve patient care?

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Register today

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Latest News

Reassuring results for ART use in BRCA breast cancer survivors

A-RT promising for high-risk patients with pancreatic cancer

YKL-40 linked to GI cancer risk in type 2 diabetes

Genetic test outplays PSA, MRI for prostate cancer screening

Dual ICIs alongside radiosurgery may increase necrosis risk

Appendiceal tumor rate validated for periappendicular abscess

Incorporating comprehensive genomic profiling into the standard-of-care for NSCLC and thyroid cancer

In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Dr. Vivek Subbiah
Dr. Alexander Drilon
Dr. Michelle Williams
Developed by: Springer Healthcare
Watch now
Video

Case Studies

Long-term outcomes after giant cavernous sinus hemangioma

Cavernous sinus hemangiomas are rare vascular tumors characterized by significant intraoperative bleeding which makes management extremely difficult. This case reports the 15 year follow up, without neurological compromise, after successful ligation of the left internal carotid artery during resection. 

Prolactinoma management: a complex path

This case highlights the challenges associated with managing an aggressive macroprolactinoma that's resistant to conventional treatments and explores the use of immunotherapy.

Skin infection or lymphoma in a woman with type 2 diabetes?

Cutaneous lymphoma should be considered in patients with long-standing, poorly controlled type 2 diabetes and chronic non-healing skin lesions. In this case, primary cutaneous B-cell lymphoma was misdiagnosed as a skin infection.

At a glance: The DESTINY-Breast trials

The antibody–drug conjugate trastuzumab deruxtecan is being investigated in the DESTINY-Breast trials for the treatment of breast cancer.

Developed by: Springer Medicine
Read more

Current Reviews

Potential Mechanisms for Immunotherapy Resistance in Adult Soft-Tissue Sarcoma

Soft-tissue sarcomas represent a diverse group of rare malignancies originating from mesenchymal tissue, accounting for less than 1% of adult cancers in the USA. With over 13,000 new cases and around 5350 deaths annually, patients with metastatic …

Emerging treatment approaches for VEXAS syndrome: a systematic review and meta-analysis

VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a monogenic autoinflammatory disorder with significant morbidity and mortality. Numerous treatment options including azacitidine, JAK inhibitors, IL-6 inhibitors …

Detection rates for prostate cancer using PI-RADS 2.1 upgrading rules in transition zone lesions align with risk assessment categories: a systematic review and meta-analysis

Magnetic resonance imaging (MRI) has become a widely utilized tool for the detection and risk stratification of prostate cancer (PCa). The Prostate Imaging Reporting and Data System version 2.1 (PI-RADS v2.1) has been established as a risk …

The Landmark Series: Organ Preservation in Rectal Cancer—The Watch and Wait Strategy

Radical treatment of rectal cancer has evolved quite significantly over the last few decades with the development of optimal local disease staging with magnetic resonance (MR), refined surgical techniques including total mesorectal excision (TME) …

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more

Most Viewed in Oncology

Managing bone metastases in gynecologic malignancies

Concerning increase in deaths due to PE in people with cancer

Fecal immunochemical test yields comparable CRC outcomes to colonoscopy screening

Appendiceal tumor rate validated for periappendicular abscess

Detection bias may explain thyroid cancer risk with GLP-1 RA use

CME & eLearning

Webinar

In this interactive webinar, experts discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations. 

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Developed by: Springer Healthcare

eLearning (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME

eLearning | Interviews | Digital Treatment Map | Patient Cases (Link opens in a new window)

0.75 AMA PRA Category 1 Credit(s)™

Expert-led, multiformat program which will address the individualized management of NSCLC, through education on the detection of NTRK gene fusions, current evidence-based guidelines, and new and emerging therapies. Will also include guidance on integrating shared decision making into your clinical practice, drawing on insights from a patient on how best to communicate.

Supported by:
  • Bayer HealthCare Pharmaceuticals Inc.
Developed by: Springer Healthcare IME

Editor's Choice | Oncology Journals

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Further Reading

Potential Mechanisms for Immunotherapy Resistance in Adult Soft-Tissue Sarcoma

Soft-tissue sarcomas represent a diverse group of rare malignancies originating from mesenchymal tissue, accounting for less than 1% of adult cancers in the USA. With over 13,000 new cases and around 5350 deaths annually, patients with metastatic …

Function-preserving gastrectomy based on the sentinel node concept prevents osteosarcopenia in patients with gastric cancer

Gastric cancer is the fifth most common malignancy worldwide and the third leading cause of cancer-related mortality [ 1 ]. According to Japanese treatment guidelines for gastric cancer, early gastric cancer (EGC) that is not eligible for …

Emerging treatment approaches for VEXAS syndrome: a systematic review and meta-analysis

VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a monogenic autoinflammatory disorder with significant morbidity and mortality. Numerous treatment options including azacitidine, JAK inhibitors, IL-6 inhibitors …

Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis

While patients with myelofibrosis (MF) face an elevated risk of thrombosis, no validated scoring system currently exists to effectively assess this specific risk. This study aimed to explore distinct molecular risk factors for arterial (ATE) and …

Related topics

Skin infection or lymphoma in a woman with type 2 diabetes?

Cutaneous lymphoma should be considered in patients with long-standing, poorly controlled type 2 diabetes and chronic non-healing skin lesions. In this case, primary cutaneous B-cell lymphoma was misdiagnosed as a skin infection.

Read more

AML secondary to CAR T-cell therapy

Managing septic shock in a pediatric AML patient

Ocular involvement in multiple myeloma

What is causing meningoencephalitis?

Evaluating pathologies of the D2 segment of the duodenum

The evolving treatment landscape of advanced prostate cancer

The advent of PSMA-targeted radioligand therapies and bispecific T-cell engagers has provided new hope for patients with metastatic castration-resistant prostate cancer. Explore the latest evidence.

Read more

Reassuring results for ART use in BRCA breast cancer survivors

A-RT promising for high-risk patients with pancreatic cancer

YKL-40 linked to GI cancer risk in type 2 diabetes

Gastric cancer guidelines: exploring international differences

Long-term outcomes after giant cavernous sinus hemangioma

Image Credits